The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced prices on 10 widely used, brand-name medications that are expensive and lack generic or biosimilar alternatives.

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

When Pam McClure learned she’d save nearly $4,000 on her prescription drugs next year, she said, “it sounded too good to be true.” She and her husband are both retired and live on a “very strict” budget in central North Dakota. By the end of this ...

Dear Toni: In 2022, I enrolled in Medicare with a supplement and a Part D plan that included my prescriptions that had copay only. But I recently noticed that the diabetic insulin I take will no longer be covered in 2025. This change will cost $391 monthly ...

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a multi-billion-dollar government

WASHINGTON -- The federal government announced a large hike in Medicare premiums Friday night, blaming the pandemic but also what it called uncertainty over how much it may have to be forced to pay for a pricey and controversial new Alzheimer's drug, CNN ...

Medicare Part D prescription drug coverage and Medicare Advantage participants will likely pay less than last year for their prescription drug coverage and plan costs. Medicare beneficiaries will see decreases in Medicare Part D and Medicare Advantage plan ...

The Inflation Reduction Act of 2022 made significant design changes to Medicare Part D effective January 1, 2025. The changes will cause an increase in the actuarial value of Medicare Part D coverage, which will impact whether a group health plan's ...